{"disease":{"id":"non-eligible-for-autologous-stem-cell-transplantation-asct","name":"non eligible for autologous stem cell transplantation asct"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05218603","title":"Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"PETHEMA Foundation","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}